Internal Medicine, Nephrology · Los Angeles, CA
NPI
1649293705
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1701 E Cesar E Chavez Ave, Suite #100
Los Angeles, CA, 90033
Phone (323) 987-1362
Groups this clinician bills Medicare through
Medicare paid, 2024
$289K
2,275 services
Medicare patients, 2024
221
Average age 70
Drug cost, 2024
$10.9M
10,630 prescriptions
Company payments, 2025
$91K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victor G Carabello was code 90960 (esrd related services (not dialysis)), 514 times for 70 patients. In total Victor G Carabello billed 2,275 services in 34 codes, and Medicare paid $289K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 514 | 70 | $285.75 | $147K |
| 99215 Office E&M - Established | Office | 303 | 88 | $144.16 | $44K |
| 99232 Hospital E&M - Subsequent | Facility | 258 | 40 | $61.47 | $16K |
| 99214 Office E&M - Established | Office | 105 | 64 | $98.48 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 58 | 23 | $92.68 | $5,376 |
| 99213 Office E&M - Established | Office | 56 | 34 | $62.15 | $3,480 |
| 99223 Hospital E&M - Initial | Facility | 51 | 41 | $132.54 | $6,759 |
| 90961 ESRD Related Services (not dialysis) | Office | 49 | 33 | $238.77 | $12K |
| 90935 Hemodialysis | Facility | 32 | 18 | $54.09 | $1,731 |
| 90962 ESRD Related Services (not dialysis) | Office | 24 | 11 | $169.67 | $4,072 |
| 99231 Hospital E&M - Subsequent | Facility | 18 | 12 | $40.28 | $725 |
| 99205 Office E&M - New | Office | 17 | 17 | $187.13 | $3,181 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 16 | 16 | $97.28 | $1,557 |
| 76881 Ultrasound - Nonspecific | Office | 13 | 11 | $40.70 | $529 |
By year: 2022 $292K for 1,508 services; 2023 $258K for 1,557 services; 2024 $289K for 2,275 services.
Medicare prescription drug claims, 2024
In 2024, the drug Victor G Carabello prescribed most often to Medicare patients was Kerendia (Finerenone), with 894 prescriptions and refills. In total Victor G Carabello wrote 10,630 Medicare prescriptions that cost $10.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Kerendia Finerenone | 894 | 974 | 141 | $597K |
| Losartan Potassium Generic | 469 | 848 | 113 | $2,505 |
| Atorvastatin Calcium Generic | 439 | 878 | 123 | $1,738 |
| Jardiance Empagliflozin | 418 | 504 | 77 | $285K |
| Farxiga Dapagliflozin Propanediol | 394 | 482 | 82 | $264K |
| Febuxostat Generic | 385 | 418 | 70 | $24K |
| Repatha Sureclick Evolocumab | 356 | 368 | 51 | $195K |
| Metformin Hcl Generic | 353 | 680 | 85 | $1,448 |
| Lokelma Sodium Zirconium Cyclosilicate | 300 | 326 | 56 | $243K |
| Furosemide Generic | 272 | 450 | 74 | $1,079 |
| Rybelsus Semaglutide | 260 | 310 | 48 | $277K |
| Amlodipine Besylate Generic | 241 | 461 | 64 | $525 |
| Auryxia Ferric Citrate | 201 | 210 | 32 | $221K |
| Omeprazole Generic | 194 | 336 | 44 | $950 |
| Tamsulosin Hcl Generic | 140 | 252 | 42 | $729 |
Brand drugs: 4,668 claims; generic drugs: 5,583 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor G Carabello $91K ($91K in general payments such as food, travel and fees) from 29 companies. The largest payer was Novo Nordisk Inc with $64K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 47 | $64K |
| Amgen Inc. AMGN | 85 | $14K |
| Travere Therapeutics, Inc. TVTX | 13 | $6,682 |
| ANI Pharmaceuticals, Inc. ANIP | 14 | $3,517 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $455 |
| Mallinckrodt Hospital Products Inc. | 13 | $331 |
| Ardelyx, Inc. ARDX | 11 | $326 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $268 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $220 |
| Calliditas Therapeutics US Inc. | 10 | $190 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.